Vaxxinity Competitors

VAXX Stock  USD 0.01  0.01  45.45%   
Vaxxinity competes with Orphazyme A/S; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Vaxxinity competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Vaxxinity to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Vaxxinity Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Vaxxinity competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vaxxinity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0351.41
Details
Intrinsic
Valuation
LowRealHigh
0.000.0251.40
Details

Vaxxinity Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Vaxxinity and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Vaxxinity and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Vaxxinity does not affect the price movement of the other competitor.

High positive correlations

QBIONNLX
EVLOPXMD
SDCCQXSNX
XSNXPXMD
EVLOTRVN
SDCCQPXMD
  

High negative correlations

TRVNXSNX
EVLOSDCCQ
TRVNPXMD
INFIQQBIO
INFIQEVLO
QBIOEVLO

Risk-Adjusted Indicators

There is a big difference between Vaxxinity Pink Sheet performing well and Vaxxinity Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vaxxinity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
PXMD  146.32  71.23  0.00  60.18  0.00 
 0.00 
 4,998 
OZYMF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
XSNX  3.52 (0.06) 0.00  0.08  0.00 
 0.00 
 150.00 
TRVN  2.01  0.50  0.00 (0.23) 0.00 
 0.00 
 106.67 
NNLX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
HLUN  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SDCCQ  3.01  0.79  0.00 (1.13) 0.00 
 0.00 
 150.00 
EVLO  16.89  5.37  0.00  0.82  0.00 
 0.00 
 400.00 
QBIO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
INFIQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Vaxxinity Competitive Analysis

The better you understand Vaxxinity competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Vaxxinity's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Vaxxinity's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
VAXX PXMD OZYMF XSNX TRVN NNLX SDCCQ EVLO QBIO
 45.45 
 0.01 
Vaxxinity
 0.00 
 0.0001 
PaxMedica,
 0.00 
 90.00 
Orphazyme
 0.00 
 0.0001 
NovAccess
 0.00 
 0.01 
Trevena
 0.00 
 0.0001 
Nanologix
 0.00 
 0.0001 
SmileDirectClub
 0.00 
 0.0005 
Evelo
 0.00 
 0.0001 
QBIO
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Price To Book
Operating Margin
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earnings To Growth
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Daily Balance Of Power
Day Typical Price
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Vaxxinity Competition Performance Charts

Five steps to successful analysis of Vaxxinity Competition

Vaxxinity's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Vaxxinity in relation to its competition. Vaxxinity's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Vaxxinity in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Vaxxinity's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Vaxxinity, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Vaxxinity position

In addition to having Vaxxinity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Beers Thematic Idea Now

Beers
Beers Theme
Companies involved in production and distribution of domestic and international beer. The Beers theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Vaxxinity Pink Sheet Analysis

When running Vaxxinity's price analysis, check to measure Vaxxinity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxxinity is operating at the current time. Most of Vaxxinity's value examination focuses on studying past and present price action to predict the probability of Vaxxinity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxxinity's price. Additionally, you may evaluate how the addition of Vaxxinity to your portfolios can decrease your overall portfolio volatility.